Home Cart 0 Sign in  

[ CAS No. 13985-15-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 13985-15-4
Chemical Structure| 13985-15-4
Structure of 13985-15-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 13985-15-4 ]

Related Doc. of [ 13985-15-4 ]

Alternatived Products of [ 13985-15-4 ]

Product Details of [ 13985-15-4 ]

CAS No. :13985-15-4 MDL No. :MFCD00183668
Formula : C20H22O4 Boiling Point : -
Linear Structure Formula :- InChI Key :FRIORIWMGKOZPB-UHFFFAOYSA-N
M.W : 326.39 Pubchem ID :14292608
Synonyms :

Calculated chemistry of [ 13985-15-4 ]

Physicochemical Properties

Num. heavy atoms : 24
Num. arom. heavy atoms : 14
Fraction Csp3 : 0.3
Num. rotatable bonds : 4
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 97.35
TPSA : 36.92 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -4.71 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.58
Log Po/w (XLOGP3) : 5.04
Log Po/w (WLOGP) : 4.64
Log Po/w (MLOGP) : 3.04
Log Po/w (SILICOS-IT) : 5.16
Consensus Log Po/w : 4.29

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -5.21
Solubility : 0.00203 mg/ml ; 0.00000622 mol/l
Class : Moderately soluble
Log S (Ali) : -5.56
Solubility : 0.000906 mg/ml ; 0.00000278 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -7.01
Solubility : 0.0000319 mg/ml ; 0.0000000977 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.81

Safety of [ 13985-15-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 13985-15-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 13985-15-4 ]

[ 13985-15-4 ] Synthesis Path-Downstream   1~85

  • 1
  • [ 13985-15-4 ]
  • [ 5629-55-0 ]
YieldReaction ConditionsOperation in experiment
With sodium dichromate; acetic acid; for 1h;Reflux; The result of step 2A-1, 2,3,6,7-tetrakis (methoxy) -9,10-dimethyl anthracene(10.0 g), sodium dichromate (50 g),Acetic acid (500 ml) was refluxed for 60 minutes to obtain 2,3,6,7-tetrakis (methoxy) anthracene-9,10-dione (2)
With sodium dichromate; acetic acid; for 1h;Reflux; A solution of 2,3,6,7-tetrakis(methoxy)-9, 10-dim-ethylanthracene (10.0 g) obtained from the step 2A-1,sodium dichromate (50 g) and acetic acid (500 ml) wasrefluxed for 60 minutes to obtain 2,3,6,7-tetrakis(methoxy)anthracene-9, 10-dione (2).10336] 2,3,6,7-tetrakis(methoxy) anthracene-9, 1 0-dione:?H NMR (600 MHz, CDC13) oe 7.32 (s, 4H), 4.06 (t, 8H),1.76 (m, 8H), 1.57 (m, 8H), 1.43-1.26 (m, 72H), 0.88 (t,1 2H)
  • 2
  • [ 91-16-7 ]
  • [ 75-07-0 ]
  • [ 13985-15-4 ]
YieldReaction ConditionsOperation in experiment
With sulfuric acid; acetic acid; In methanol; for 23h; The cooled solution of veratrol (32 mL) and acetic acid (125 mL) was slowly added to a cooled solution of methanol (20 mL) and acetaldehyde (21 mL). The mixed solution was thoroughly stirred for 1 hour, then concentrated sulfuric acid (95%, 125 mL) was added over 2 hours and reacted with stirring for 20 hours. After the reaction was completed, the reaction mixture was poured into ice water to terminate the reaction. The reaction mixture was filtered, washed with water and subjected to column chromatography using chloroform as a developing solution to obtain 2,3,6,7-tetrakis (methoxy) -9, 10-Dimethylanthracene (1) was isolated.
The cooled solution of veratrol (32 ml) and acetic acid (125 ml) was slowly added to a cooled solution of methanol (20 ml) and acetaldehyde (21 ml). The mixed solution was thoroughly stirred for 1 hour, then concentrated sulthric acid (95%, 125 ml) was added over 2 hours and reacted with stirring for 20 hours. Afier the reaction was completed, the reaction mixture was poured into ice water to terminate the reaction. The reaction mixture was filtered, washed with water and subjected to colunm chromatography using chloroform as a developing solution to obtain isolated 2,3,6,7-tetrakis(methoxy)-9, 1 0-dimethylanthracene (1)
  • 3
  • [ 13985-15-4 ]
  • [ 13979-56-1 ]
YieldReaction ConditionsOperation in experiment
66% With boron tribromide; In dichloromethane; FIG. 17 shows schematically the methods by which the substituted precursor compounds were prepared. The tested products are labelled CMR 1 (R1-R4=-OCH3); CMR 4 (R1-R4=-CO2CH3); and CMR 6 (R1-R4?N-substituted cyclic imido).
  • 4
  • [ 13985-15-4 ]
  • C20H23O4(1+) [ No CAS ]
  • 5
  • [ 13985-15-4 ]
  • [ 13985-15-4 ]
  • 6
  • [ 13985-15-4 ]
  • [ 108-24-7 ]
  • [ 13979-55-0 ]
  • 7
  • [ 5385-63-7 ]
  • [ 123-63-7 ]
  • [ 13985-15-4 ]
  • 8
  • [ 13671-28-8 ]
  • [ 77-48-5 ]
  • [ 13985-15-4 ]
  • 1-(2,6)pyridina-5-(9,10)-2,3,6,7-tetramethoxyanthracena-3,7-dithiacyclooctaphane [ No CAS ]
  • 10
  • [ 13985-15-4 ]
  • [ 7697-37-2 ]
  • [ 5629-55-0 ]
  • 11
  • [ 13985-15-4 ]
  • [ 64-19-7 ]
  • aqueous CrO3-solution [ No CAS ]
  • [ 5629-55-0 ]
  • 13
  • [ 13985-15-4 ]
  • [ 4661-46-5 ]
  • [ 876460-50-3 ]
  • 16
  • [ 13985-15-4 ]
  • 5-(10-bromo-2,3,6,7-tetramethoxyanthracen-9-yl)pyrimidin-2-amine [ No CAS ]
  • 17
  • [ 13985-15-4 ]
  • 5,5'-(2,3,6,7-tetramethoxyanthracene-9,10-diyl)bis[pyrimidin-2-amine] [ No CAS ]
  • 18
  • [ 13985-15-4 ]
  • 2-[5-(10-bromo-2,3,6,7-tetramethoxy-anthracen-9-yl)-pyrimidin-2-yl]-isoindole-1,3-dione [ No CAS ]
  • 19
  • [ 13985-15-4 ]
  • C42H28N6O8 [ No CAS ]
  • 20
  • [ 13985-15-4 ]
  • [ 885675-51-4 ]
  • 21
  • [ 13985-15-4 ]
  • 2,3,6,7-tetrakis(decyloxy)-9,10-dihydroanthracene [ No CAS ]
  • 22
  • [ 13985-15-4 ]
  • [ 885675-49-0 ]
  • 23
  • [ 13985-15-4 ]
  • [ 885675-47-8 ]
  • 24
  • [ 13985-15-4 ]
  • [ 885675-53-6 ]
  • 25
  • [ 13985-15-4 ]
  • 5,5'-[2,3,6,7-tetrakis(decyloxy)anthracene-9,10-diyl]bis[pyrimidin-2-amine] [ No CAS ]
  • 26
  • [ 13985-15-4 ]
  • C78H100N6O8 [ No CAS ]
  • 30
  • [ 13985-15-4 ]
  • [ 876460-51-4 ]
  • 31
  • [ 13985-15-4 ]
  • C46H66O16 [ No CAS ]
  • 32
  • [ 13985-15-4 ]
  • [ 118514-20-8 ]
  • 33
  • [ 13985-15-4 ]
  • [ 92103-71-4 ]
  • 34
  • [ 13985-15-4 ]
  • [ 3178-75-4 ]
  • 35
  • [ 13985-15-4 ]
  • [ 13979-52-7 ]
  • 36
  • [ 13985-15-4 ]
  • [ 13979-57-2 ]
  • 37
  • [ 13985-15-4 ]
  • 2,3,6,7-Tetrahydroxy-anthron [ No CAS ]
  • 38
  • [ 13985-15-4 ]
  • C20H22O4(1+)*Cl6Sb(1-) [ No CAS ]
  • 39
  • [ 13985-15-4 ]
  • 4,5-dimethoxy-2-aminobenzoic acid diazonium salt [ No CAS ]
  • [ 865539-65-7 ]
  • 40
  • [ 13985-15-4 ]
  • 2,3,6,7-tetrahydroxy-9,10-dimethyl-13-phenyl-9,10-dihydro-9,10-[3,4]epipyrroloanthracene-12,14-dione [ No CAS ]
  • 41
  • [ 13985-15-4 ]
  • 2,3,6,7-tetrahydroxy-9,10-dimethyl-13-(4-methylphenyl)-9,10-dihydro-9,10-[3,4]epipyrroloanthracene-12,14-dione [ No CAS ]
  • 42
  • [ 13985-15-4 ]
  • 2,3,6,7-tetrahydroxy-9,10-dimethyl-13-(2,4,6-trimethylphenyl)-9,10-dihydro-9,10-[3,4]epipyrroloanthracene-12,14-dione [ No CAS ]
  • 43
  • [ 13985-15-4 ]
  • 2,3,6,7-tetrahydroxy-9,10-dimethyl-13-(4-(t-butyl)phenyl)-9,10-dihydro-9,10-[3,4]epipyrroloanthracene-12,14-dione [ No CAS ]
  • 44
  • [ 13985-15-4 ]
  • 2,3,6,7-tetrahydroxy-9,10-dimethyl-13-(4-ethoxyphenyl)-9,10-dihydro-9,10-[3,4]epipyrroloanthracene-12,14-dione [ No CAS ]
  • 45
  • [ 13985-15-4 ]
  • 2,3,6,7-tetramethoxy-9,10-dimethyl-13-phenyl-9,10-dihydro-9,10-[3,4]epipyrroloanthracene-12,14-dione [ No CAS ]
  • 46
  • [ 13985-15-4 ]
  • 2,3,6,7-tetramethoxy-9,10-dimethyl-13-(4-methylphenyl)-9,10-dihydro-9,10-[3,4]epipyrroloanthracene-12,14-dione [ No CAS ]
  • 47
  • [ 13985-15-4 ]
  • 2,3,6,7-tetramethoxy-9,10-dimethyl-13-(2,4,6-trimethylphenyl)-9,10-dihydro-9,10-[3,4]epipyrroloanthracene-12,14-dione [ No CAS ]
  • 48
  • [ 13985-15-4 ]
  • 2,3,6,7-tetramethoxy-9,10-dibutyl-13-(4-(t-butyl)phenyl)-9,10-dihydro-9,10-[3,4]epipyrroloanthracene-12,14-dione [ No CAS ]
  • 49
  • [ 13985-15-4 ]
  • 2,3,6,7-tetramethoxy-9,10-dimethyl-13-(4-ethoxyphenyl)-9,10-dihydro-9,10-[3,4]epipyrroloanthracene-12,14-dione [ No CAS ]
  • 50
  • [ 108-31-6 ]
  • [ 13985-15-4 ]
  • 2,3,6,7-tetramethoxy-9,10-dimethyl-9,10,11,15-tetrahydro-9,10-[3,4]furanoanthracene-12,14-dione [ No CAS ]
  • 52
  • [ 13985-15-4 ]
  • C34H30O8 [ No CAS ]
  • 53
  • [ 13985-15-4 ]
  • C32H26O8 [ No CAS ]
  • 54
  • [ 13985-15-4 ]
  • C20H10F12O12S4 [ No CAS ]
  • 55
  • [ 13985-15-4 ]
  • 2,3,6,7-tetramethoxy-9,10-bis(bromomethyl)anthracene [ No CAS ]
YieldReaction ConditionsOperation in experiment
97% With N-Bromosuccinimide; 1,1'-azobis(1-cyanocyclohexanenitrile); In dichloromethane; FIG. 17 shows schematically the methods by which the substituted precursor compounds were prepared. The tested products are labelled CMR 1 (R1-R4=-OCH3); CMR 4 (R1-R4=-CO2CH3); and CMR 6 (R1-R4?N-substituted cyclic imido).
71% With N-Bromosuccinimide; In dichloromethane; for 4h;Inert atmosphere; Reflux; Under an inert N2 atmosphere, 91 (2 g, 6.1 mmol), NBS (4 g, 22.6 mmol) and ABCN (73 mg, 0.3 mmol) were dissolved in anhydrous dichloromethane (150 mL), and the mixture stirred at reflux for 4 hours. The mixture was then cooled to 0 C and filtered. The solid was then dried under high vacuum to afford 92 (2.1 g, 4.3 mmcl, 71%) as a bright yellow solid. 1H NMR (400 MHz, CDCI3) O 4.11 (s, 12H, C(1)H), 5.35 (s, 4H, C(6)H), 7.40 (s, 4H, C(3)H), 13C NMR (100 MHz, CDCI3) 28.7(06), 56.0 (Cl), 101.8(03), 125.7(05), 125.9(04), 150.1 (02).
  • 56
  • [ 13985-15-4 ]
  • 2,3,6,7-tetramethoxy-9,10-bis(aminomethyl)anthracene [ No CAS ]
  • 57
  • [ 13985-15-4 ]
  • tetra-tert-butyl 2,2‘,2“,2'''-((9,10-dimethylanthracene-2,3,6,7-tetrayl)tetrakis(oxy))tetraacetate [ No CAS ]
  • 58
  • [ 13985-15-4 ]
  • tetra-tert-butyl 2,2‘,2”,2“-((9,10-bis(bromomethyl)anthracene-2,3,6,7-tetrayl)tetrakis(oxy))tetraacetate [ No CAS ]
  • 59
  • [ 13985-15-4 ]
  • C24H22O8 [ No CAS ]
  • 60
  • [ 13985-15-4 ]
  • C20H14O8 [ No CAS ]
  • 61
  • [ 13985-15-4 ]
  • tetra-tert-butyl-2,2‘,2”,2'''-((9,10-bis(azidomethyl)anthracene-2,3,6,7-tetrayl)tetrakis(oxy)) tetraacetate [ No CAS ]
  • 62
  • [ 13985-15-4 ]
  • tetra-tert-butyl-2,2‘,2”,2'''-((9,10-bis(aminomethyl)anthracene-2,3,6,7-tetrayl)tetrakis(oxy)) tetraacetate [ No CAS ]
  • 63
  • [ 13985-15-4 ]
  • C32H32N2O8 [ No CAS ]
  • 64
  • [ 13985-15-4 ]
  • 2-Carboxy-4-nitro-benzenediazonium; chloride [ No CAS ]
  • C26H25NO6 [ No CAS ]
YieldReaction ConditionsOperation in experiment
15% With methyloxirane; In 1,2-dichloro-ethane; General procedure: To a gently refluxing solution of the anthracene (1a-1c) (1mmol) in 1,2-dichloroethane (50mL) was added portionwise 5-nitrobenzenediazonium-2-carboxylate (2.5mmol). When TLC showed that the starting anthracene was consumed, the reaction mixture was concentrated under reduce pressure. The residue was purified by flash column chromatography on silica gel with petroleum ether: CH2Cl2=4:1 (v/v) as eluent to yield the triptycene as a pale yellow solid. 2b: 67mg, 15% yield. 1H NMR (300MHz, CDCl3): delta 8.08 (s, 1H), 7.87 (d, 1H, J=6.9Hz), 7.37 (d, 1H, J=8.2Hz), 6.98 (s, 2H), 6.97 (s, 2H), 3.86 (s, 12H), 2.46 (s, 3H), 2.43 (s, 3H). 13C NMR (75MHz, CDCl3): delta 156.4, 151.2, 146.3, 146.2, 145.1, 140.4, 139.9, 120.9, 120.4, 115.0, 106.2, 106.0, 56.42, 56.38, 48.5, 48.3, 13.9, 13.7. EI-TOF-MS: m/z 447 [M]+. Anal. calcd. for C26H25NO6·0.1CH2Cl2: C, 68.75; H, 5.57; N, 3.07. Found: C, 68.81; H, 5.80; N, 2.97.
  • 65
  • [ 13985-15-4 ]
  • C26H27NO4 [ No CAS ]
  • 66
  • [ 13985-15-4 ]
  • C55H54N2O8 [ No CAS ]
  • 67
  • [ 13985-15-4 ]
  • 5,5'-(2,3,6,7-tetramethoxyanthracene-9,10-diyl)diisophthalic acid [ No CAS ]
  • 68
  • [ 13985-15-4 ]
  • 2C34H24O12(2-)*2Ba(2+)*2C5H9NO [ No CAS ]
  • 69
  • [ 13985-15-4 ]
  • C38H34O12 [ No CAS ]
  • 70
  • [ 14104-20-2 ]
  • dichloro(pentamethylcyclopentadienyl)rhodium (III) dimer [ No CAS ]
  • [ 13985-15-4 ]
  • [(C5Me5)Rh(η6-2,3,6,7-tetramethoxy-9,10-dimethylanthracene)](BF4)2 [ No CAS ]
  • 71
  • [ 107799-44-0 ]
  • [ 13985-15-4 ]
  • [(C5H5)Ru(η6-2,3,6,7-tetramethoxy-9,10-dimethylanthracene)]BF4 [ No CAS ]
  • 72
  • [ 107799-44-0 ]
  • [ 13985-15-4 ]
  • [(C5H5)Ru(η6-2,3,6,7-tetramethoxy-9,10-dimethylanthracene)]BF4 [ No CAS ]
  • [(C5H5)Ru(η6-2,3,6,7-tetramethoxy-9,10-dimethylanthracene)]BF4 [ No CAS ]
  • 73
  • [ 107799-44-0 ]
  • [ 13985-15-4 ]
  • [(C5H5)Ru(η6-2,3,6,7-tetramethoxy-9,10-dimethylanthracene)]BF4 [ No CAS ]
  • 74
  • [ 14104-20-2 ]
  • chloro(1,5-cyclooctadiene)rhodium(I) dimer [ No CAS ]
  • [ 13985-15-4 ]
  • [(η4-cyclooctadiene)Rh(η6-2,3,6,7-tetramethoxy-9,10-dimethylanthracene)]BF4 [ No CAS ]
  • 75
  • [ 91-16-7 ]
  • [ 64-17-5 ]
  • [ 13985-15-4 ]
  • 76
  • [ 13985-15-4 ]
  • C14H8Br2O4 [ No CAS ]
  • 77
  • [ 13985-15-4 ]
  • C50H60Br2O16 [ No CAS ]
  • 78
  • [ 13985-15-4 ]
  • 2,3,6,7-tetrakis(dodecyloxy)anthracene-9,10-dione [ No CAS ]
  • 79
  • [ 13985-15-4 ]
  • 2,3,6,7-tetrakis(dodecyloxy)anthracene [ No CAS ]
  • 80
  • [ 13985-15-4 ]
  • 2,3,6,7-tetrakis(dodecyloxy)anthracene-9-one [ No CAS ]
  • 81
  • [ 13985-15-4 ]
  • 2,3,6,7-tetramethoxy-9,10-bis(azidomethyl)anthracene [ No CAS ]
  • 82
  • [ 13985-15-4 ]
  • 9,10-bis(isocyanatomethyl)-2,3,6,7-tetramethoxyanthracene [ No CAS ]
  • 83
  • [ 13985-15-4 ]
  • 9-bromo-2,3,6,7-tetramethoxyanthracene [ No CAS ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 3 steps 1: acetic acid / 1 h / Reflux 2: sodium hydroxide; zinc / water / 48 h / 100 °C / Inert atmosphere 3: copper(ll) bromide / chloroform / 70 °C
  • 84
  • [ 13985-15-4 ]
  • 1,4-bis(2,3,6,7-tetramethoxyanthracen-9-yl)benzene [ No CAS ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 4 steps 1: acetic acid / 1 h / Reflux 2: sodium hydroxide; zinc / water / 48 h / 100 °C / Inert atmosphere 3: copper(ll) bromide / chloroform / 70 °C 4: tetrakis(triphenylphosphine) palladium(0); potassium carbonate / water; toluene; ethanol / Inert atmosphere; Reflux
  • 85
  • [ 13985-15-4 ]
  • 9,9’-(1,4-phenylene)bis(anthracene-2,3,6,7-tetraol) [ No CAS ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 5 steps 1: acetic acid / 1 h / Reflux 2: sodium hydroxide; zinc / water / 48 h / 100 °C / Inert atmosphere 3: copper(ll) bromide / chloroform / 70 °C 4: tetrakis(triphenylphosphine) palladium(0); potassium carbonate / water; toluene; ethanol / Inert atmosphere; Reflux 5: boron tribromide / dichloromethane / 96 h / 20 °C / Inert atmosphere
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 13985-15-4 ]

Aryls

Chemical Structure| 4676-58-8

[ 4676-58-8 ]

2,3-Dimethoxy-6,7-dimethylnaphthalene

Similarity: 0.90

Chemical Structure| 93-51-6

[ 93-51-6 ]

2-Methoxy-4-methylphenol

Similarity: 0.86

Chemical Structure| 1195-09-1

[ 1195-09-1 ]

2-Methoxy-5-methylphenol

Similarity: 0.86

Chemical Structure| 1131-53-9

[ 1131-53-9 ]

2-Methoxy-7-methylnaphthalene

Similarity: 0.86

Chemical Structure| 26386-94-7

[ 26386-94-7 ]

2-Methoxy-6-methylnaphthalene

Similarity: 0.86

Ethers

Chemical Structure| 4676-58-8

[ 4676-58-8 ]

2,3-Dimethoxy-6,7-dimethylnaphthalene

Similarity: 0.90

Chemical Structure| 93-51-6

[ 93-51-6 ]

2-Methoxy-4-methylphenol

Similarity: 0.86

Chemical Structure| 1195-09-1

[ 1195-09-1 ]

2-Methoxy-5-methylphenol

Similarity: 0.86

Chemical Structure| 1131-53-9

[ 1131-53-9 ]

2-Methoxy-7-methylnaphthalene

Similarity: 0.86

Chemical Structure| 26386-94-7

[ 26386-94-7 ]

2-Methoxy-6-methylnaphthalene

Similarity: 0.86